Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sanofi-Aventis buys 25% stake in Zentiva for €430mm

Executive Summary

Giving it a stronger presence in the European branded generics market, Sanofi-Aventis has acquired a 25% stake in Czech pharmaceuticals company Zentiva. For a total of €430mm ($518mm), Sanofi bought approximately 9.5mm shares--7.5mm shares previously held by Zentiva's former largest shareholder Warburg Pincus, and rest from current and former Zentiva managers and employees.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity

Related Companies